Effect of rhBMP-2 immobilized anorganic bovine bone matrix on bone regeneration

International Journal of Molecular Sciences

Volumn 16, Issue 7, 2015, Pages 16034-16052

  Huh, Jung Bo ^a   Yang, June Jip ^b   Choi, Kyung Hee ^c   Bae, Ji Hyeon ^a   Lee, Jeong Yeol ^b   Kim, Sung Eun ^d   Shin, Sang Wan ^b  

^a Pusan National University   (South Korea)

^b Korea University   (South Korea)

^c Research and Development Institute   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Anorganic bovine bone; Bio Oss ; Bone regeneration; RhBMP 2

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BIO-OSS; BONE MORPHOGENETIC PROTEIN 2; IMMOBILIZED PROTEIN; MINERAL; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GRAFT; BONE MATRIX; BONE REGENERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HISTOMETRY; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; RABBIT; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; X RAY PHOTOELECTRON SPECTROSCOPY; ANIMAL; BONE DISEASES; BOVINE; CHEMISTRY; CONFOCAL MICROSCOPY; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG EFFECTS; HUMAN; PATHOLOGY; SKULL; X-RAY COMPUTED TOMOGRAPHY;

ANIMALIA; BOVINAE; ORYCTOLAGUS CUNICULUS;

ANIMALS; BONE DISEASES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CATTLE; DISEASE MODELS, ANIMAL; HUMANS; IMMOBILIZED PROTEINS; MALE; MICROSCOPY, CONFOCAL; MINERALS; PHOTOELECTRON SPECTROSCOPY; RABBITS; RECOMBINANT PROTEINS; SKULL; SURFACE PROPERTIES; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 84937250166     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160716034     Document Type: Article

References (38)

1. Rocchietta, I.; Fontana, F.; Simion, M. Clinical outcomes of vertical bone augmentation to enable dental implant placement: A systematic review. J. Clin. Periodontal. 2008, 5, 203–215.
2. Blokhuis, T.J.; Arts, J.J. Bioactive and osteoinductive bone graft substitutes: Definitions, facts and myths. Injury 2011, 42, S26–S29.
3. Nkenke, E.; Weisbach, V.; Winckler, E.; Kessler, P.; Schultze-Mosgau, S.; Wiltfang, J.; Neukam, F.W. Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: A prospective study. Int. J. Oral Maxillofac. Surg. 2004, 33, 157–163.
4. Zhou, X.; Zhang, Z.; Li, S.; Bai, Y.; Xu, H. Osteoconduction of different sizes of anorganic bone particles in a model of guided bone regeneration. Br. J. Oral Maxillofac. Surg. 2011, 49, 37–41.
5. Esposito, M.; Grusovin, M.G.; Kwan, S.; Worthington, H.V.; Coulthard, P. Interventions for replacing missing teeth: Bone augmentation techniques for dental implant treatment. Cochrane Database Syst. Rev. 2008, 16, CD003607.
6. Amerio, P.; Vianale, G.; Reale, M.; Muraro, R.; Tulli, A.; Piattelli, A. The effect of deproteinized bovine bone on osteoblast growth factors and proinflammatory cytokine production. Clin. Oral Implant. Res. 2010, 21, 650–655.
7. Scarano, A.; Degidi, M.; Iezzi, G.; Pecora, G.; Piattelli, M.; Orsini, G.; Caputi, S.; Perrotti, V.; Mangano, C.; Piattelli, A. Maxillary sinus augmentation with different biomaterials: A comparative histologic and histomorphometric study in man. Implant. Dent. 2006, 15, 197–207.
8. Turhani, D.; Weißenböck, M.; Watzinger, E.; Yerit, K.; Cvikl, B.; Ewers, R.; Thurnher, D. In vitro study of adherent mandibular osteoblast-like cells on carrier materials. Int. J. Oral Maxillofac. Surg. 2005, 34, 543–550.
9. Ripamonti, U.; Reddi, A.H. Periodontal regeneration: Potential role of bone morphogenetic proteins. J. Periodont. Res. 1994, 29, 225–235.
10. Urist, M.R. Bone: Formation by autoinduction. Science 1965, 150, 893–899.
11. Higuchi, T.; Kinoshita, A.; Takahashi, K.; Oda, S.; Ishikawa, I. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J. Periodontol. 1999, 70, 1026–1031.
12. Govender, S.; Csimma, C.; Genant, H.K.; Valentin-Opran, A.; Amit, Y.; Arbel, R.; Aro, H.; Atar, D.; Bishay, M.; Borner, M.G.et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibia fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Jt. Surg. Am. Vol. 2002, 84, 2123–2134.
13. Jung, R.E.; Windisch, S.I.; Eggenschwiler, A.M.; Thoma, D.S.; Weber, F.E.; Hammerle, C.H. A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2. Clin. Oral Implant. Res. 2009, 20, 660–666.
14. Hunt, D.R.; Jovanovic, S.A.; Wikesjo, U.M.; Wozney, J.M.; Bernard, G.W. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study. J. Periodontol. 2001, 72, 651–658.
15. Sigurdsson, T.J.; Nygaard, L.; Tatakis, D.N.; Fu, E.; Turek, T.J.; Jin, L.; Wozney, J.M.; Wikesjö, U.M. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int. J. Periodontics Restor. Dent. 1996, 16, 524–537.
16. Barboza, E.P.; Duarte, M.E.; Geolás, L.; Sorensen, R.G.; Riedel, G.E.; Wikesjö, U.M. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J. Periodontol. 2000, 71, 488–496.
17. Kato, M.; Toyoda, H.; Namikawa, T.; Hoshino, M.; Terai, H.; Miyamoto, S.; Takaoka, K. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials 2006, 27, 2035–2041.
18. Jeon, O.; Song, S.J.; Yang, H.S.; Bhang, S.H.; Kang, S.W.; Sung, M.A.; Lee, J.H.; Kim, B.S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem. Biophys. Res. Commun. 2008, 369, 774–780.
19. Sasisekharan, R.; Ernst, S.; Venkataraman, G. On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycan. Angiogenesis 1997, 1, 45–54.
20. Lin, H.; Zhao, Y.; Sun, W.; Chen, B.; Zhang, J.; Zhao, W.; Xiao, Z.; Dai, J. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2. Biomaterials 2008, 29, 1189–1197.
21. Kübler, A.; Neugebauer, J.; Oh, J.H.; Scheer, M.; Zöller, J.E. Growth and proliferation of human osteoblasts on different bone graft substitutes: An in vitro study. Implant Dent. 2004, 13, 171–179.
22. Jung, R.E.; Glauser, R.; Schärer, P.; Hämmerle, C.H.; Sailer, H.F.; Weber, F.E. Effect of rhBMP-2 on guided bone regeneration in humans. Clin. Oral Implant. Res. 2003, 14, 556–568.
23. Hänseler, P.; Ehrbar, M.; Kruse, A.; Fischer, E.; Schibli, R.; Ghayor, C.; Weber, F.E. Delivery of BMP-2 by two clinically available apatite materials: In vitro and in vivo comparison. J. Biomed. Mater. Res. A 2015, 103, 628–638.
24. Uludag, H.; DʼAugusta, D.; Palmer, R.; Timony, G.; Wozney, J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater. Res. 1999, 46, 193–202.
25. Cho, T.J.; Gerstenfeld, L.C.; Einhorn, T.A. Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing. J. Bone Miner. Res. 2002, 17, 513–520.
26. Haidar, Z.S.; Hamdy, R.C.; Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery. Biotechnol. Lett. 2009, 31, 1817–1824.
27. Haidar, Z.S.; Hamdy, R.C.; Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopedic and craniofacial tissue engineering. Biotechnol. Lett. 2009, 31, 1825–1835.
28. Huh, J.B.; Kim, S.E.; Song, S.K.; Yun, M.J.; Shim, J.S.; Lee, J.Y.; Shin, S.W. The effect of immobilization of heparin and bone morphogenic protein-2 to bovine bone substitute on osteoblast-like cell’s function. J. Adv. Prosthodontics 2011, 3, 145–151.
29. Zhao, B.; Katagiri, T.; Toyoda, H.; Takada, T.; Yanai, T.; Fukuda, T.; Chung, U.I.; Koike, T.; Takaoka, K.; Kamijo, R. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J. Biol. Chem. 2006, 281, 23246–23253.
30. Bhakta, G.; Rai, B.; Lim, Z.X.; Hui, J.H.; Stein, G.S.; van Wijnen, A.J.; Nurcombe, V.; Prestwich, G.D.; Cool, S.M. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 2012, 33, 6113–6122.
31. Kim, S.E.; Song, S.H.; Yun, Y.P.; Choi, B.J.; Kwon, I.K.; Bae, M.S.; Moon, H.J.; Kwon, Y.D. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011, 32, 366–373.
32. Kodama, T.; Goto, T.; Miyazaki, T.; Takahashi, T. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin. Int. J. Oral Maxillofac. Implant. 2008, 23, 1013–1019.
33. Jo, J.Y.; Jeong, S.I.; Shin, Y.M.; Kang, S.S.; Kim, S.E.; Jeong, C.M.; Huh, J.B. Sequential delivery of BMP-2 and BMP-7 for bone regeneration using a heparinized collagen membrane. Int. J. Oral Maxillofac. Surg. 2015, 44, 921–928.
34. Kim, S.E.; Kim, C.S.; Yun, Y.P.; Yang, D.H.; Park, K.; Kim, S.E.; Jeong, C.M.; Huh, J.B. Improving osteoblast functions and bone formation upon BMP-2 immobilization on titanium modified with heparin. Carbohydr. Polym. 2014, 19, 123–132.
35. Kim, S.E.; Yun, Y.P.; Lee, J.Y.; Shim, J.S.; Park, K.; Huh, J.B. Co-delivery of platelet-derived growth factor (PDGF-BB) and bone morphogenic protein (BMP-2) coated onto heparinized titanium for improving osteoblast function and osteointegration. J. Tissue Eng. Regen. Med. 2013, doi:10.1002/term.1668.
36. Jung, R.E.; Weber, F.E.; Thoma, D.S.; Ehrbar, M.; Cochran, D.L.; Hammerle, C.H. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate. Clin. Oral Implant. Res. 2008, 19, 188–195.
37. Tatakis, D.N.; Koh, A.; Jin, L.; Wozney, J.M.; Rohrer, M.D.; Wikesjo, U.M. Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J. Periodontal Res. 2002, 37, 93–100.
38. Liu, H.W.; Chen, C.H.; Tsai, C.L.; Lin, I.H.; Hsiue, G.H. Heterobifunctional poly(ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. Tissue Eng. 2007, 13, 1113–1124.